Business Development of MediClin in FY 2011

Frankfurt am Main, March 22, 2012 – The Members of the Management Board of MEDICLIN Aktiengesellschaft (MediClin) said at this year’s balance sheet press conference that they are satisfied with the results of FY 2011 especially against the background of new legal regulations, which don’ t or only limited allow to rise costs. “The requirements for medical services are increasing all the time, the willingness to honour more quality in the treatments not. Therefore the solution can only be an integrated cross-sector medical care, which allows an efficient treatment on a high quality level”, said Frank Abele, Chairman of the management Board..

Group sales increase by 1.3% to EUR 493.6 mill.
Group sales was EUR 493.6 mill.,about EUR 6,4 mill. or 1.3 % above the previous year’s value. In the post-acute segment sales increased from EUR 275.2 mill. to EUR 279.3 mill. despite the slight decrease in occupancy. In the acute segment, salesincreased by EUR 0.6 mill., from EUR 200.3 mill. to EUR 200.9 mill. Of the remainingsales increase totalling EUR 1.7 mill., EUR 0.8 mill. was derived from the nursing carebusiness area. The service business area, which is also assigned to the other activitiessegment, recorded an increase in sales, too.

Group operating result (earnings before interest and taxes) was EUR 10.9 mill.,which was EUR 6.0 mill. lower than the previous year. In the post-acute segment, thesegment result decreased von EUR 6.2 mill. to EUR 2,8 mill. and the acute segment result decreased fromEUR 18.2 mill. toEUR 15.2 mill. Despite the rise in sales, the cost of raw materials and consumables used wasEUR 110.4 mill., nearly on the same level as the previous year. Personnel costs increased by EUR 11.6 mill. up to EUR 278.6 mill. compared to the previous year.

A total of EUR 29.9 mill. was invested in 2011, or EUR 6.6 mill. more than in theprevious year. A further EUR 15.9 mill. was spent on maintenance. On the 2011 balancesheet date, with liquid funds of EUR 41.3 mill., MediClin had enough cash and cashequivalents to finance further growth.

Capacity expansion in the segments to secure future internal growth
In the post-acute segment the bed capacity was significantly increased in neurology and psychosomatics as aresult of higher demand. The expansion of the service range in these specialist medicalfields reflects corporate strategy to concentrate on specific areas that correspond to growing demand. The bed capacity in the acute segment was alsoexpanded over the course of the financial year. Inthe coming years, a rising occupancy rates for these additional capacities is expected.

Outlook
In 2012, MediClin will continue on the path that it has embarked upon – providing crosssector,integrated, patient-focused care that is close to patients’ homes. Opportunities sees MediClin in the shareholding of the Asklepios Group. The Management Board anticipates additional growth potential as overlaps in the servicerangeonly exist at a few locations.

The refinancing of existing loan obligations totalling EUR 61.4 mill. will have apositive effect in the 2012 financial year. Accordingly, updated interest rates lead toexpectations of a better financial result from 2012 onwards.

Overall, should the framework conditions in the industry and the referral practices ofcoverage providers not change drastically in 2012, the Management Board expects anincrease in sales and a solid earnings performance for the current financial year.

The annual report 2011is availableon www.mediclin.de in German and English.

Key figures - yoy comparison and quarterly development Group and segments

Über die MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungs-zentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,100 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin
has approximately 8,300 employees.

Important notice:
This press release includes future-oriented statements which are based on assumptions and estimates. While MediClin AG is of the opinion that these assumptions and estimates are correct, the actual future developments and actual future results may deviate from these assumptions and estimates due to the impact of various factors such as changes in the economic conditions in Germany, legal changes concerning the health system, changes relating to cost providers’ expense behaviour. MediClin does not assume liability and gives no warranty that future developments and the income actually achieved in the future will comply with the assumptions and estimates stated in this press release.